YOLFTbeta
00

Lifecome Biochemistry Co Ltd

002868 · SHE · Healthcare / Biotechnology

17.99CNY-0.32 (-1.75%)

Price History

Full chart

Market Stats

Previous Close18.31
Open18.52
Day Range17.92 – 18.66
52-Week Range20.77 – 48.72
Volume1.05M
Market Cap3.50B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.48
Dividend Yield0.00%
Beta0.79
50-Day Avg22.92
200-Day Avg31.66

About

Lifecome Biochemistry Co.,Ltd. engages in research, development, production, and sales of veterinary drugs in China. It offers probiotics and green microbial functional additives; biopesticides, biofertilizers, and pesticide formulations; and food additives. The company was founded in 2003 and is based in Pucheng, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMs. Jing Yang
  • Employees549
  • HeadquartersNo. 6, Yuanyuan Road, Pucheng, China, 353400, China
  • Websitehttps://pclifecome.com

Leadership

  • Ms. Jing YangActing GM & Director · b. 1986
  • Mr. Zhongshou BaoFinancial Director · b. 1970
  • Xiaohong WangAccounting Supervisor
  • Mr. Guo Feng GaoSecretary of Board · b. 1984

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue306.56M297.15M295.78M385.61M401.49M375.41M344.29M303.76M308.15M363.39M329.85M507.00M649.37M516.58M
Growth (%)--3.07%-0.46%+30.37%+4.12%-6.50%-8.29%-11.77%+1.44%+17.93%-9.23%+53.71%+28.08%-20.45%
Cost of Revenue208.96M211.81M210.99M243.70M244.04M225.41M228.22M205.03M216.43M311.55M381.36M611.75M756.06M481.95M
Gross Profit97.60M85.34M84.79M141.91M157.45M150.01M116.08M98.73M91.71M51.84M-51.51M-104.74M-106.69M34.63M
Gross Margin31.84%28.72%28.67%36.80%39.22%39.96%33.71%32.50%29.76%14.27%-15.62%-20.66%-16.43%6.70%
Operating Expense39.08M57.14M51.92M54.06M53.14M49.43M28.88M31.74M43.69M84.92M82.25M131.39M321.33M163.02M
Operating Income58.51M28.20M32.87M87.85M104.31M100.57M87.20M66.99M48.02M-33.08M-133.76M-236.13M-428.02M-128.39M
Operating Margin19.09%9.49%11.11%22.78%25.98%26.79%25.33%22.05%15.58%-9.10%-40.55%-46.57%-65.91%-24.85%
EBITDA51.30M48.58M75.18M128.22M139.77M128.84M116.88M95.76M79.88M4.67M-53.55M-133.60M-269.17M13.07M
EBITDA Margin16.74%16.35%25.42%33.25%34.81%34.32%33.95%31.52%25.92%1.28%-16.24%-26.35%-41.45%2.53%
Net Income43.24M32.97M31.45M78.10M92.36M85.92M74.69M56.97M43.21M-26.04M-121.94M-221.82M-444.86M-139.26M
Net Income Margin14.11%11.10%10.63%20.25%23.00%22.89%21.69%18.75%14.02%-7.17%-36.97%-43.75%-68.51%-26.96%
R&D11.72M14.54M11.77M13.02M13.17M14.11M14.57M18.55M19.91M24.82M21.82M27.53M40.08M25.60M
R&D as % of Total Revenue3.82%4.89%3.98%3.38%3.28%3.76%4.23%6.11%6.46%6.83%6.62%5.43%6.17%4.96%
Interest Expense-8.78M10.71M8.43M2.94M390.29K22.20K1.13M980.57K3.15M16.46M38.02M62.51M53.74M
Interest Expense % of Total Revenue-2.95%3.62%2.19%0.73%0.10%0.01%0.37%0.32%0.87%4.99%7.50%9.63%10.40%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets371.37M395.88M390.09M392.52M370.66M756.25M802.42M1.01B972.50M1.26B1.24B1.97B1.49B748.71M
Total Liabilities214.92M226.45M199.22M153.54M99.32M60.56M62.05M231.55M202.56M536.38M640.56M1.55B1.52B683.78M
Total Equity156.45M169.42M190.87M238.98M271.34M695.68M740.37M774.43M765.15M717.63M595.69M411.29M-26.27M63.18M
Cash17.53M7.93M10.00M7.77M15.62M71.74M68.69M114.31M194.26M97.50M23.76M84.38M24.80M55.60M
Total Debt100.24M125.43M142.50M83.31M33.21M1.22M-121.84M82.08M307.67M357.26M962.73M330.24M186.27M
Net Debt82.71M117.50M132.49M75.54M17.60M-70.52M-68.69M7.53M-112.19M210.17M333.50M878.34M305.44M130.67M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow60.92M77.68M62.76M127.11M135.41M96.11M83.70M74.09M90.72M35.17M-8.83M-186.76M141.41M-25.08M
Investing Cash Flow-43.84M-57.08M-22.22M-31.30M-14.15M-342.82M-55.95M-123.14M86.58M-355.01M-136.86M-254.25M-89.82M-135.26M
Financing Cash Flow-4.43M-30.83M-38.38M-98.05M-113.51M305.30M-30.69M94.37M-94.76M223.87M70.76M467.45M-79.58M195.44M
Capital Expenditure49.25M57.00M24.66M39.65M14.82M18.56M48.93M125.60M253.79M357.17M137.32M464.54M125.06M129.80M
Free Cash Flow11.66M20.68M38.10M87.46M120.59M77.54M34.76M-51.51M-163.07M-322.00M-146.15M-651.30M16.35M-154.88M
Dividends Paid39.45M27.43M18.54M37.63M62.66M30.43M30.02M30.00M20.07M21.48M12.99M24.22M48.83M42.52M
FCF to OCF19.15%26.62%60.70%68.81%89.05%80.68%41.54%-69.53%-179.75%-915.53%1654.63%348.74%11.56%617.58%
Dividend Paid to FCF338.23%132.63%48.66%43.03%51.96%39.24%86.36%-58.24%-12.31%-6.67%-8.89%-3.72%298.62%-27.46%

Earnings

Report DateJun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 27, 2020Aug 29, 2020Oct 31, 2020Mar 16, 2021Apr 30, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 29, 2024May 20, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 20, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------
EPS Actual0.130.160.090.120.150.120.100.070.090.060.140.110.310.05-0.000.020.03-0.08-0.13-0.06-0.18-0.20-0.35-0.07-0.24-0.26-0.88-0.20-0.36-0.45-1.85-0.19-0.19-0.15-0.360.040.01
Surprise-------------------------------------
Timing--------------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap3.50B
Enterprise Value3.82B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.45
Price / Book50.12
EPS-0.48
Book Value0.457
Revenue (TTM)470.43M
Gross Profit (TTM)58.60M
EBITDA41.36M
Profit Margin-15.60%
Operating Margin1.28%
Return on Equity-1189.13%
Return on Assets-1.58%
Shares Outstanding155.42M
Shares Float45.79M
Beta0.79
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20211×
0.14May 21, 2021
20201×
0.13May 28, 2020
20191×
0.19May 24, 2019
20181×
0.19Jun 11, 2018
20171×
0.19Jun 29, 2017

Stock Splits

  • May 28, 20201.3:1